Press Releases
Biorce Takes Aika 2.0 to BIO 2026
Biorce brings Aika 2.0 to BIO 2026 with live demo rides in San Diego

Biorce is bringing its citywide Aika 2.0 live-demo ride experience to BIO International Convention in San Diego, continuing to redefine drug development.
San Diego, United States - [June 19, 2026] - Biorce, the AI-native clinical development company that raised more than $60 million in under 12 months, today announced the expansion of its Aika 2.0 launch campaign to the BIO International Convention 2026 in San Diego.
Building on the momentum generated at ASCO 2026, where oncology leaders experienced Aika 2.0 through private live-demo rides across Chicago, Biorce is once again skipping the traditional conference booth and bringing the product directly to attendees.
Throughout BIO 2026, convention participants will be able to book private rides across San Diego and experience live demonstrations of Aika 2.0, the first AI-powered end-to-end operating system for clinical development, inside the vehicle.
"The response at ASCO exceeded our expectations," said Pedro Coelho, Founder and CEO of Biorce. "People just didn't want another booth demo. They wanted to see how AI can actually transform clinical development workflows. The ride experience created real conversations, real engagement, and real understanding of what's possible. We're excited to bring that same energy to BIO."
Aika 2.0 enables biotech, pharma, and CROs to generate protocols, simulations, feasibility assessments, budgets, contracts, and regulatory documentation in minutes. The platform sits on top of existing enterprise architecture, integrating seamlessly across systems and workflows. Every output remains continuously updated, creating an intelligent layer across the entire clinical trial lifecycle. Outputs are traceable, audit-ready, and defensible, aligned with FDA and EMA requirements. Biorce brings clinical and scientific rigor to technology, not the other way around. The company has developed the industry's most robust clinical data ontology, validated by clinical and scientific experts. Learn more about Aika 2.0 here: biorce.com/aika-2.0.
About Biorce
Biorce is an AI healthtech startup, building defensible AI solutions for clinical trial development. Its platform, Aika, is a continuous intelligent layer, from protocol decision to regulatory submission, enabling fewer amendments and a dramatic reduction of cost and time.
Media contact
Lynn Caroline Broeker
PR & Media collaborations
lynn.broeker@biorce.com







